Pelvi-périnéologie

, Volume 5, Issue 4, pp 261–266 | Cite as

Constipation iatrogène

  • J. Kerdraon
  • M. Eleouet
  • P. Coignard
  • L. Siproudhis
Mise Au Point / Update
  • 65 Downloads

Résumé

Avec le bilan d’organicité, l’identification des causes iatrogènes médicamenteuses constitue la première étape du bilan étiologique d’une constipation. Son expression peut aller du simple inconfort passager à une occlusion sur iléus paralytique. L’éviction du médicament iatrogène n’est pas toujours possible, comme lors des traitements antiparkinsoniens, certains traitements antidépresseurs ou l’analgésie aux opiacés. Une analyse systématique des facteurs iatrogènes non médicamenteux est de ce fait d’autant plus indispensable, tout particulièrement chez la personne âgée ou les sujets institutionnalisés.

Mots clés

Constipation Iatrogénicité Médicaments 

Iatrogenic constipation

Abstract

With evident symptoms of organicity, identifying medication causes may be the first step in the etiology of constipation. Its expression can range from transient discomfort to an occlusion on paralytic ileus. The eviction of iatrogenic medication is not always possible, as in some Parkinson’s treatments, antidepressants, or opiate analgesia. A systematic analysis of other iatrogenic factors is therefore all the more essential, especially in elderly or institutionalized subjects.

Keywords

Constipation Iatrogenic Medications 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Leong RW, Chan FK (2006) Chan, drug-induced side effects affecting the gastrointestinal tract. Expert Opin Drug Saf 5(4):585–92CrossRefPubMedGoogle Scholar
  2. 2.
    Keating C, Martinez V, Ewart L, et al (2010) The validation of an in vitro colonic motility assay as a biomarker for gastrointestinal adverse drug reactions. Toxicol Appl Pharmacol 245(3):299–309CrossRefPubMedGoogle Scholar
  3. 3.
    Kanjanarat P, Winterstein AG, Johns TE, et al (2003) Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 60(17):1750–9PubMedGoogle Scholar
  4. 4.
    Sharma RK (1988) Vincristine and gastrointestinal transit. Gastroenterology 95(5):1435–6PubMedGoogle Scholar
  5. 5.
    Wood JD (2002) Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol 35(1Suppl):S11–22CrossRefPubMedGoogle Scholar
  6. 6.
    Stewart RB, Moore MT, Marks RG, Hale WE (1992) Correlates of constipation in an ambulatory elderly population. Am J Gastroenterol 87(7):859–64PubMedGoogle Scholar
  7. 7.
    Whitehead WE, Drinkwater D, Cheskin LJ, et al (1989) Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc 37(5):423–9PubMedGoogle Scholar
  8. 8.
    Monane M, Avorn J, Beers MH, Everitt DE (1993) Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med 153(5):633–8CrossRefPubMedGoogle Scholar
  9. 9.
    Talley NJ, Fleming KC, Evans JM, et al (1996) Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 91(1):19–25PubMedGoogle Scholar
  10. 10.
    van Dijk KN, de Vries CS, van den Berg PB, et al (1998) Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk. Br J Clin Pharmacol 46(3):255–61CrossRefPubMedGoogle Scholar
  11. 11.
    Fonda D, DuBeau CE, Harari D, et al (2009) Incontinence in the frail elderly. In: 4th International Consultation on Incontinence. Abrams P, Cardozo L, Khoury S, Wein A (eds) Health Publications Ltd, Plymouth, pp 1163–240Google Scholar
  12. 12.
    Zeino Z, Sisson G, Bjarnason I (2010) Adverse effects of drugs on small intestine and colon. Best Pract Res Clin Gastroenterol 24(2):133–41CrossRefPubMedGoogle Scholar
  13. 13.
    Sharma S, Longo WE, Baniadam B, Vernava AM 3rd (1995) Colorectal manifestations of endocrine disease. Dis Colon Rectum 38(3):318–23CrossRefPubMedGoogle Scholar
  14. 14.
    Elliot DL, Watts WJ, Girard DE (1983) Constipation. Mechanisms and management of a common clinical problem. Postgrad Med 74(2):143–9PubMedGoogle Scholar
  15. 15.
    Brown WJ, Mishra G, Lee C, Bauman A (2000) Leisure time physical activity in Australian women: relationship with well being and symptoms. Res Q Exerc Sport 71(3):206–16PubMedGoogle Scholar
  16. 16.
    Tobin GW, Brocklehurst JC (1986) Faecal incontinence in residential homes for the elderly: prevalence, aetiology and management. Age Ageing 15(1):41–6CrossRefPubMedGoogle Scholar
  17. 17.
    Robson KM, Kiely DK, Lembo T (2000) Development of constipation in nursing home residents. Dis Colon Rectum 43(7):940–3CrossRefPubMedGoogle Scholar
  18. 18.
    White H (2004) Making toilets more accessible for individuals with a disability. In: Bowel Continence Nursing, CS Norton C, (ed), Beaconsfield’s Publishers, Beaconsfield, UKGoogle Scholar
  19. 19.
    Read NW, Celik AF, Katsinelos P (1995) Constipation and incontinence in the elderly. J Clin Gastroenterol 20(1):61–70CrossRefPubMedGoogle Scholar
  20. 20.
    Klauser AG, Beck A, Schindlbeck NE, Müller-Lissner SA (1990) Low fluid intake lowers stool output in healthy male volunteers. Z Gastroenterol 28(11):606–9PubMedGoogle Scholar
  21. 21.
    Ziegenhagen DJ, Tewinkel G, Kruis W, Herrmann F (1991) Adding more fluid to wheat bran has no significant effects on intestinal functions of healthy subjects. J Clin Gastroenterol 13(5):525–30CrossRefPubMedGoogle Scholar
  22. 22.
    Towers AL, Burgio KL, Locher JL, et al (1994) Constipation in the elderly: influence of dietary, psychological, and physiological factors. J Am Geriatr Soc 42(7):701–6PubMedGoogle Scholar
  23. 23.
    Piche T, Dapoigny M, Bouteloup C, et al (2007) [Recommendations for the clinical management and treatment of chronic constipation in adults]. Gastroenterol Clin Biol 31(2):125–35CrossRefPubMedGoogle Scholar
  24. 24.
    Sandler RS, Jordan MC, Shelton BJ (1990) Demographic and dietary determinants of constipation in the US population. Am J Public Health 80(2):185–9CrossRefPubMedGoogle Scholar
  25. 25.
    Wald A (1993) Constipation in elderly patients. Pathogenesis and management. Drugs Aging 3(3):220–31CrossRefPubMedGoogle Scholar
  26. 26.
    Beaugerie L (1996) Toxicité intestinale des médicaments (estomac et duodénum exclus). In: Encyclopédie médicochirurgicale, E Masson, (ed), ParisGoogle Scholar
  27. 27.
    Merkel IS, Locher J, Burgio K, et al (1993) Physiologic and psychologic characteristics of an elderly population with chronic constipation. Am J Gastroenterol 88(11):1854–9PubMedGoogle Scholar
  28. 28.
    Clemens KE, Mikus G (2010) Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain. Expert Opin Pharmacother 11(2):297–310CrossRefPubMedGoogle Scholar
  29. 29.
    Baker DE (2009) Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction. Rev Gastroenterol Disord 9(3):E84–93PubMedGoogle Scholar
  30. 30.
    Eadie MJ, Tyrer JH (1965) Alimentary disorder in parkinsonism. Australas Ann Med 14:13–22PubMedGoogle Scholar
  31. 31.
    Edwards LL, Pfeiffer RF, Quigley EM, et al (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6(2):151–6CrossRefPubMedGoogle Scholar

Copyright information

© Springer Paris 2010

Authors and Affiliations

  • J. Kerdraon
    • 1
    • 2
  • M. Eleouet
    • 2
  • P. Coignard
    • 1
  • L. Siproudhis
    • 2
  1. 1.Service de réeducation neurologique adulteCMRRF de KerpapePloemeur cedexFrance
  2. 2.Centre de référence Spina Bifida, pavillon Pointeau-du-RoncerayCHU PontchaillouRennes cedex 09France

Personalised recommendations